SCHEMBL13305093

SCHEMBL13305093

Bc1cnn2c(NCc3ccc(NCCN(C)C)nc3)cc(C3CCN(C(=O)OCc4ccccc4)CC3)nc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPC3 Q13507 2/20 0.41
▸ TRPC7 Q9HCX4 2/20 0.41
▸ GRIN2B Q13224 7/20 0.40
▸ GSK3B P49841 3/20 0.39
▸ CYP2D6 P10635 4/20 0.39
▸ CYP2C9 P11712 4/20 0.39
▸ CYP3A4 P08684 3/20 0.39
▸ USP30 Q70CQ3 1/20 0.38
▸ CHEK1 O14757 1/20 0.37
▸ CCNA2 P20248 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ CCNA1 P78396 1/20 0.37
▸ ENPP2 Q13822 1/20 0.37
▸ F13A1 P00488 1/20 0.36
▸ TGM2 P21980 1/20 0.36
▸ TGM1 P22735 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12953829 0.92 GSK3B (0.49) TRPC3TRPC7GRIN2BGSK3BCYP2D6
SCHEMBL13305198 0.84 GSK3B (0.56) TRPC3TRPC7GRIN2BGSK3BCYP2D6
SCHEMBL14043203 0.84 TRPC3 (0.44) TRPC3TRPC7GRIN2BGSK3BCYP2D6
SCHEMBL13304833 0.82 CA2 (0.52) TRPC3TRPC7GRIN2BGSK3BCYP2D6
SCHEMBL13305170 0.80 TRPC3 (0.43) TRPC3TRPC7GRIN2BGSK3BCYP2D6
SCHEMBL13146084 0.78 GSK3B (0.49) GSK3BCDK2MAPK1KDM4ENPC1
SCHEMBL13304793 0.78 MAPK1 (0.41) GRIN2BGSK3BCYP2D6CYP2C9CYP3A4
SCHEMBL13305133 0.78 TRPC3 (0.53) TRPC3TRPC7GRIN2BCYP2D6CYP2C9
SCHEMBL12953919 0.76 TRPC3 (0.53) TRPC3TRPC7GRIN2BCYP2D6CYP2C9
SCHEMBL12953650 0.76 GSK3B (0.54) TRPC3TRPC7GRIN2BGSK3BCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537116-B1 PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES SCHERING CORP (US) 2010-06-02 — — EP disclosed
Send feedback